These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Convergence in findings from randomized trials and elaborately analysed observational data on mortality reduction with carvedilol in heart failure in comparison with metoprolol. Chakraborty A; Chatterjee S Eur J Heart Fail; 2014 Jun; 16(6):595-7. PubMed ID: 24863629 [No Abstract] [Full Text] [Related]
28. Beta-blocker therapy for heart failure: the evidence is in, now the work begins. Califf RM; O'Connor CM JAMA; 2000 Mar; 283(10):1335-7. PubMed ID: 10714735 [No Abstract] [Full Text] [Related]
29. Phosphodiesterase inhibitors in refractory heart failure: bridge to beta-blockade? De Marco T; Chatterjee K J Am Coll Cardiol; 1998 May; 31(6):1341-3. PubMed ID: 9581730 [No Abstract] [Full Text] [Related]
30. Effect of beta blockers on mortality and morbidity in persons treated for congestive heart failure. Aronow WS J Am Geriatr Soc; 2001 Mar; 49(3):331-3. PubMed ID: 11300246 [No Abstract] [Full Text] [Related]
31. [Treatment of cardiovascular diseases with beta-blockers: the place of metoprolol and its various drug formulations]. Martsevich SIu Kardiologiia; 2003; 43(12):78-81. PubMed ID: 15035258 [No Abstract] [Full Text] [Related]
32. Safety and effectiveness data: will children gain access? Schreiner MS Am Heart J; 1998 Jul; 136(1):4-5. PubMed ID: 9665210 [No Abstract] [Full Text] [Related]
33. Study documents benefits of beta-blockers in heart failure. Miller JL Am J Health Syst Pharm; 2000 Apr; 57(8):729-30. PubMed ID: 10786255 [No Abstract] [Full Text] [Related]
34. Low-dose beta blockade in the treatment of chronic cardiac failure. Weber KT; Likoff MJ; McCarthy D Am Heart J; 1982 Oct; 104(4 Pt 1):877-9. PubMed ID: 6127026 [No Abstract] [Full Text] [Related]
35. Should manipulation of myocardial substrate utilization patterns be a component of the congestive heart failure therapeutic paradigm? From AH J Card Fail; 1998 Jun; 4(2):127-9. PubMed ID: 9730106 [No Abstract] [Full Text] [Related]
36. [Frequent drug interactions in old age]. Wagner CC; Locher P; Elke B; Corti N Praxis (Bern 1994); 2009 Oct; 98(21):1185-90; quiz 1191-2. PubMed ID: 19844875 [No Abstract] [Full Text] [Related]
37. Efficacy observation and analysis of metoprolol combined with dopamine in patients with severe pneumonia complicated with heart failure. Yang F; Yu J; Dong W; Han W; Qiao C; Wang Y Panminerva Med; 2022 Sep; 64(3):404-405. PubMed ID: 34114761 [No Abstract] [Full Text] [Related]
38. Evaluation of ultrasonic indexes and exercise endurance application of diuretic mixture combined with metoprolol in the treatment of senile chronic heart failure. Yin Z; Wang L; Zhang Y; Shan T Minerva Surg; 2022 Feb; 77(1):92-94. PubMed ID: 34160180 [No Abstract] [Full Text] [Related]
39. Searching for treatments of heart failure with preserved ejection fraction: matching the data to the question. Cheng S; Pfeffer MA JAMA; 2014 Nov; 312(19):1977-8. PubMed ID: 25399271 [No Abstract] [Full Text] [Related]
40. Betablockers in the New Millennium. Hamburg meeting, April 1, 2000. Proceedings. Basic Res Cardiol; 2000; 95 Suppl 1():I1-103. PubMed ID: 11236746 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]